SPRY ARS Corp: Uzoq muddatli qarzning kapitalga koeffitsiyenti
ARS Pharmaceuticals (SPRY) ignasiz dori yetkazib berish usullarini yaratishga ixtisoslashgan bo'lib, anafilaktik shok bilan kurashish uchun noyob burun mahsulotini ishlab chiqmoqda. GURU.Markets platformasida kompaniya aksiyalarining kunlik narx harakati hozirda 7.81 darajasida turibdi. Biroq, biznesni rivojlantirish xomashyo logistikasini buzadigan va yangi dori vositalarining xalqaro tasdiqlanishini sekinlashtiradigan global siyosiy tarangliklar tufayli murakkablashgan.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_SPRY_-_ARS-Pharmaceuticals_-_Long-Term-Debt-to-Capital "SPRY: ARS Pharmaceuticals, Inc. Uzoq muddatli qarzning kapitalga nisbati 28.04.2023 - 28.10.2026 | 👁️GURU.Markets👁️")
ARS Pharmaceuticals (SPRY) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati ARS Pharmaceuticals|SPRY - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ars-pharma.com|SPRY - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati ARS Pharmaceuticals, Inc.|SPRY - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz ARS Pharmaceuticals
Kompaniyaning dastlabki tahlili:ARS Pharmaceuticals Inc
ARS Pharmaceuticals (SPRY) kompaniyasining uzoq muddatli moliyaviy barqarorligini baholash uchun muddati bir yildan ortiq bo'lgan majburiyatlarning kapitalga nisbatini tahlil qilish juda muhimdir. Uzoq muddatli qarzlarning kapitalga nisbati leveraj darajasini belgilaydi, bunda past ko'rsatkich butilovchi liniyalarning texnik qayta jihozlanishi va burun spreyini ishlab chiqarish quvvatlarini kengaytirish davrida defolt xatarlarini minimallashtiradi.
ARS Pharmaceuticals kimlar bilan raqobatlashadi
Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati Haleon PLC|Kenvue Corp (KVUE) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Verona Pharma Inc. (VRNA)|Uzoq muddatli qarzning kapitalga nisbati MENS (Jyong Biotech Ltd)|ligand.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Amneal (AMRX)|PRGO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|ALVO (Alvotech Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Liquidia Inc. (LQDA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|GLPG (Galapagos NV) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati anipharmaceuticals.com (ANIP)|MannKind (MNKD) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti AMPH (Amphastar Pharmaceuticals Inc)|PCRX: Uzoq muddatli qarzning o'z kapitaliga nisbati|TBPH - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Aquestive Therapeutics AQST|SCPH - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati tectonictx.com TECX|Tonix Pharma (TNXP) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SXTC (SXT Pharmaceuticals)|Uzoq muddatli majburiyatlarning kapitalga nisbati EPRX|BioHarvest Sciences (BHST) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti invizyne.com (EXOZ)|Uzoq muddatli qarzning kapitalga nisbati ORMP (Oramed Pharmaceuticals Inc.)|Entera Bio Ltd - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati MindWalk (HYFT)|ABVC: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Cumberland Pharmaceuticals - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati quantumbiopharma.com|FGEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TELO|RANI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati synergychc.com (SNYR)|Uzoq muddatli qarzning kapitalga nisbati Rallybio|Uzoq muddatli qarzning kapitalga koeffitsiyenti Lexaria Bioscience Corp LEXX|Pulmatrix - Uzoq muddatli qarzning kapitalga nisbati|PTHL: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati aptorumgroup.com APM|LYRA (Lyra Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati IBO|Uzoq muddatli qarzning o'z kapitaliga nisbati TNF Pharma|Uzoq muddatli qarzning kapitalga nisbati YCBD|Uzoq muddatli qarzning kapitalga nisbati PainReform Ltd (PRFX)|Altamira Therapeutics Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Lipella Pharma LIPO|OPTN (OptiNose, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|pieris.com (PIRS) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PROC: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Petros Pharmaceuticals Inc|Qilian International Holding Group Limited (QLI) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ACELYRIN Inc.|TFFP (TFF Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati